CD8A and COVID-19: Interestingly, we identified highly activated CD16+CD8+ T cells (CD8T_act_effector) with strong cytotoxic functions and high similarity to CD16+CD8+ T cells previously identified in the blood of patients with severe COVID-19 (ref. 29).